Your session is about to expire
← Back to Search
CBG Effects in Healthy Participants
Study Summary
This trial is designed to study the effects of a cannabis plant constituent, cannabigerol (CBG), on healthy adults. The study will use a placebo-controlled, double-blind design, meaning that neither the participants nor the researchers will know who is receiving the CBG until after the study is completed. The study will consist of 5 conditions, with increasing doses of CBG given orally. Each condition will last for 8 hours, during which time the effects of the CBG will be studied.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I am in good health as confirmed by recent medical exams and tests.I am not using, or unwilling to use, birth control.I haven't taken any prescription drugs that could affect the study in the last 14 days, except for birth control.I am between 18 and 55 years old.I have epilepsy or a history of seizures.I haven't taken any over-the-counter drugs, supplements, or vitamins in the last 14 days that could affect the study.I tested negative for drugs and alcohol during my screening visit.I have a history of serious heart rhythm problems or spasm-related chest pain.I have used cannabis before but not in the last 30 days.Your weight is within a healthy range for your height.I have used cannabis before but not in the last 30 days.
- Group 1: Oral administration of 25mg CBG
- Group 2: Oral administration of 50mg CBG
- Group 3: Oral administration of 100mg CBG
- Group 4: Oral administration of 200mg CBG
- Group 5: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are people currently signing up to participate in this research?
"This study, which is currently seeking participants, was first posted on 8/9/2022 and last edited on 8/16/2022."
How many people are being recruited for this clinical trial?
"That is correct. The clinicaltrials.gov website shows that this trial, which was originally advertised on 8/9/2022, is still looking for participants. They need 30 individuals total from 1 medical facility."
Are people who are over 25 years old able to participate in this research project?
"Enrolment in this particular study is open to patients that are between 18-55 years old. If the patient does not fall into this age category, there are 49 other trials they could potentially enroll in."
Is it dangerous to consume Oral CBG Cannabis?
"Oral CBG Cannabis received a score of 1 for safety. This is due to Phase 1 trials having limited data supporting both safety and efficacy."
Are there any inclusions or exclusions for this research project?
"This clinical trial is enrolling 30 individuals who have previously abused hashish. Patients must be between 18-55 years old and meet the following requirements: They must have given written informed consent, be in good general health based on physical examination, medical history, vital signs, and screening urine/blood tests, test negative for recent cannabis use in urine at Screening Visit and again upon admission for experimental sessions, test negative for other drugs of abuse including alcohol at the Screening Visit and upon arrival for experimental session, not be pregnant or nursing (if female), have a body mass index (BMI) in the range of 18-"
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger